Faeth Therapeutics, Inc. valuation and forecast
Explore the models for Faeth Therapeutics, Inc., adjust their assumptions and compare your own valuation with the platform's.
Your valuation workspace
What is FTH worth to you?
Start with the company's financial data. Make the assumptions your own.
01 / Assumptions
Follow the forecast
The cash flows behind your value
View annual figures
| Forecast year | Cash flow / share |
|---|
Negative cash flows are shown in terracotta. Before the terminal value and equity bridge. Residual-income models show excess earnings; dividend models show dividends.
See the range of possibilities
Compare and combine your models
Weights start with the platform's included models. Change them to build your own combination. Select a model name to edit its assumptions.
| Model | Your value / share | Weight |
|---|
The platform's price and consistency filters are not reapplied to your scenarios.
Other model types 21 unavailable for FTH
Price-to-earnings vs peers
no positive earnings in the latest twelve months
Justified price-to-book
return on equity is not positive
Revenue-to-maturity model
revenue and margins don't support a positive value
Price-to-sales vs peers
no positive revenue in the latest twelve months
Cash-flow DCF
This model does not apply to this company with the available financial data.
Growth DCF
This model does not apply to this company with the available financial data.
P/B vs return on equity
This model does not apply to this company with the available financial data.
Peer price-to-book
This model does not apply to this company with the available financial data.
Peer price-to-FFO
This model does not apply to this company with the available financial data.
Forward peer P/E
This model does not apply to this company with the available financial data.
Forward peer price-to-sales
This model does not apply to this company with the available financial data.
P/E comparison
This model does not apply to this company with the available financial data.
P/S comparison
This model does not apply to this company with the available financial data.
PEG comparison
This model does not apply to this company with the available financial data.
Two-stage dividend discount
This model does not apply to this company with the available financial data.
Growing-dividend model
This model does not apply to this company with the available financial data.
REIT funds from operations
This model does not apply to this company with the available financial data.
Utility earnings
This model does not apply to this company with the available financial data.
Book value / net assets
This model does not apply to this company with the available financial data.
Reported crypto treasury NAV
This model does not apply to this company with the available financial data.
Proved-reserve NAV
This model does not apply to this company with the available financial data.
Model values are estimates under the assumptions shown. They are not share-price forecasts or investment advice.
Analyst recommendations
Monthly trend
- Oct 202615
- Sep 202614
- Aug 202612
- Jul 202610
Counts of recommendations published by analysts covering Faeth Therapeutics, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
FTH valuation questions
- How does Fundamentalytics value Faeth Therapeutics, Inc.?
- We use the models that fit Faeth Therapeutics, Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 3, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Faeth Therapeutics, Inc.